Maple syrup urine disease in treated patients: Biochemical and oxidative stress profiles

Clinical Biochemistry

Volumn 41, Issue 4-5, 2008, Pages 317-324

  Barschak, Alethéa G ^a,b   Marchesan, Christiane ^c   Sitta, Angela ^a,b   Deon, Marion ^a,b   Giugliani, Roberto ^b   Wajner, Moacir ^a,b   Vargas, Carmen Regla ^a,b,c  

^a Instituto de Ciencias Biologicas e da Saude Pontifical Catholic University of Minas Gerais   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c PPGCF   (Brazil)

Author keywords

Antioxidant reactivity; Biochemical profile; Lipid peroxidation; Maple syrup urine disease

Indexed keywords

ALBUMIN; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CREATININE; GLUCOSE; LACTATE DEHYDROGENASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALBUMIN BLOOD LEVEL; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIET THERAPY; ENZYME ACTIVITY; EVALUATION; GLUCOSE BLOOD LEVEL; HUMAN; INFANT; LIPID PEROXIDATION; MAPLE SYRUP URINE DISEASE; OXIDATIVE STRESS; PLASMA; PRESCHOOL CHILD; PRIORITY JOURNAL;

ANTIOXIDANTS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CREATINE; GLUCOSE; HUMANS; HYDRO-LYASES; INFANT; INFANT, NEWBORN; MAPLE SYRUP URINE DISEASE; OXIDATIVE STRESS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRANSAMINASES; TRIGLYCERIDES; UREA; URIC ACID;

EID: 39149102127     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.11.015     Document Type: Article

References (28)

1. Chuang D.T., and Shih V.E. Maple syrup urine disease (branched-chain ketoaciduria). In: Scriver C.R., Beaudt A.L., Sly W.L., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease. 8ed (2001), McGraw-Hill, New York 1971-2005
2. Schadewaldt P., and Wendel U. Metabolism of branched-chain amino acids in maple syrup urine disease. Eur J Pediatr 156 Suppl. 1 (1997) S62-S66
3. Schadewaldt P., and Wendel U. Variant maple syrup urine disease (MSUD)-the entire spectrum. J Inherit Metab Dis 29 6 (2006) 716-724
4. Schönberger S., Schweiger B., Schwahn B., Schwarz M., and Wendel U. Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab 82 1 (2004) 69-75
5. Strauss K.A., and Morton D.H. Branched-chain ketoacyl dehydrogenase deficiency: maple syrup disease. Curr Treat Option Neurol 5 4 (2003) 329-341
6. Halliwell B., and Gutteridge J.C. Free radicals in biology and medicine. 3th ed (2001), Oxford, New York
7. Harris E.D. Regulation of antioxidant enzymes. Faseb J 6 9 (1992) 2675-2683
8. Pawlak W., Kedziora J., Zolynski K., et al. Effect of long term bed rest in man on enzymatic antioxidative defence and lipid peroxidation in erythrocytes. J Gravit Physiol 1 (1998) 163-164
9. Beckman K.B., and Ames B.N. The free theory of aging matures. Phisiol Rev 78 2 (1998) 547-581
10. Colome C., Sierra C., and Vilaseca M.A. Congenital errors of metabolism: cause of oxidative stress?. Méd Clin 115 (2000) 111-117
11. Fontella F.U., Pulrolnik V., Wannmacher C.M.D., et al. Propionic and l-methylmalonic acids induce oxidative stress in brain of young rats. Neuro Report 11 (2000) 541-544
12. de Oliveira Marques F., Hagen M.E., and Pederzolli C.D. Glutaric acid induces oxidative stress in brain of young rats. Brain Res 964 (2003) 153-158
13. Fontella F.U., Gassen E., Pulrolnik V., et al. Stimulation of lipid peroxidation in vitro in rat brain by metabolites accumulating in maple syrup urine disease. Metab Brain Dis 17 (2002) 47-54
14. Bridi R., Araldi J., Sgarbi M.B., et al. Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease. Int J Devl Neuroscience 21 (2003) 327-332
15. Wajner M., Latini A., Wyse A.T.S., and Dutra-Filho C.S. The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis 27 (2004) 427-448
16. Sirtori L.R., Dutra-Filho C.S., Fitarelli D., et al. Oxidative stress in patient with phenylketonuria. Biochim Biophys Acta 1740 (2005) 68-73
17. Sitta A., Barschak A.G., Deon M., et al. Investigation of oxidative stress parameters in treated phenylketonuric patients. Metab Brain Dis 20 (2006) 287-296
18. Vargas C.R., Wajner M., Sirtori L.R., et al. Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochim Biophys Acta 1688 (2004) 26-32
19. Deon M., Wajner M., Sirtori L.R., et al. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy. J Neurol Sci 247 (2006) 157-164
20. Barschak A.G., Sitta A., Deon M., et al. Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease. Metab Brain Dis 20 (2006) 279-286
21. Joseph M.H., and Marsden C.A. Amino acids and small peptides. In: Lim C.F. (Ed). HPLC of Small Peptides (1986), IRL Press, Oxford 13-27
22. Buege J.A., and Aust S.D. Microsomal lipid peroxidation. Methods Enzymol 52 (1978) 302-309
23. Lissi E., Pascual C., and Del Castillo M.D. Luminol luminescence induced by 2,2′-azo-bis-(2-amidinopropane) thermolysis. Free Radic Res Commun 17 (1992) 299-311
24. In: Burtis C.A., and Ashwood E.R. (Eds). Tietz: Fundamentos de Química Clínica. 4°edição (1998), Guanabara-Koogan, Rio de Janeiro
25. Lott J.A., and Landesman P.W. The enzymology of skeletal muscle disorders. Crit Rev Clin Lab Sci 20 2 (1984) 153-190
26. Nathwani R.A., Pais S., Reynolds T.B., and Kaplowitz N. Serum alanine aminotransferase in skeletal muscle diseases. Hepatology 41 2 (2005) 380-382
27. Esterbauer H., and Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186 (1990) 407-421
28. Lissi E., Salim-Hanna M., Pascual C., and Del Castillo M.D. Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. Free Radic Biol Med 18 (1995) 153-158